European Medical Solutions (FRA:AS0) COGS-to-Revenue : 0.71 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is European Medical Solutions COGS-to-Revenue?

European Medical Solutions's Cost of Goods Sold for the six months ended in Dec. 2023 was €13.98 Mil. Its Revenue for the six months ended in Dec. 2023 was €19.75 Mil.

European Medical Solutions's COGS to Revenue for the six months ended in Dec. 2023 was 0.71.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. European Medical Solutions's Gross Margin % for the six months ended in Dec. 2023 was 29.19%.

European Medical Solutions COGS-to-Revenue Historical Data

The historical data trend for European Medical Solutions's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Medical Solutions COGS-to-Revenue Chart

European Medical Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

0.65

0.67

European Medical Solutions Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	0.62	0.69	0.63	0.71

European Medical Solutions COGS-to-Revenue Calculation

European Medical Solutions's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.053	/	40.564
	=	0.67

European Medical Solutions's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	13.984	/	19.748
	=	0.71

European Medical Solutions (FRA:AS0) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

European Medical Solutions's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	13.984 / 19.748
	=	29.19 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

European Medical Solutions COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of European Medical Solutions's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

European Medical Solutions (FRA:AS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » European Medical Solutions (FRA:AS0) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

ALIMG:Belgium

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

European Medical Solutions (FRA:AS0) Headlines

No Headlines